All stock lists
Arvinas, Inc. (NASDAQ:ARVN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.75-0.01 (-0.19%)
Market cap
$441M
Insider Score
Health Score
Analyst consensus
Listed since
Sep 27, 2018
Website
Insider Score
––Not scored
ARVN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
ARVN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ARVN patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ARVN from public contracts
Source: USAspending.gov
Recently reported changes in ARVN holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing ARVN, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for ARVN. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.